Body size, physical activity, and Hodgkin's disease risk
体型、体力活动和霍奇金病风险
基本信息
- 批准号:6838960
- 负责人:
- 金额:$ 6.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-01 至 2006-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Hodgkin's disease (HD) is a common cancer of young adults for which etiology is far from established, and few novel leads have been identified. Scattered reports have linked HD risk with taller height, heavier weight and less physical activity. Body size and physical activity are believed to affect immune function and hormone regulation, both postulated as relevant to HD etiology, but their impact on HD risk has had very little consideration, especially in women. We propose to examine risk for HD in women associated with body size and physical activity over the life-span to test the hypotheses that: 1) Height in adulthood and relative height in childhood are associated with increased HD risk. 2) Birth weight and weight adjusted for height (body mass index) throughout adulthood are associated with HD risk. 3) Frequency of strenuous physical activity in adolescence and through adulthood is associated with HD risk. We will address these topics in data from detailed in-person interviews collected for a completed population-based case-control study of HD in women that had a high response rate, histologically re-reviewed diagnoses, and nearly complete data on 312 cases and 325 random-digit dialing controls frequency-matched to cases on age and race. With logistic regression, we will compute odds ratios to estimate risk associated with: adult height; relative height at ages 8 and 12; birth weight; weight adjusted for height through adulthood; and frequency of leisure-time strenuous physical activity through adolescence and adulthood and physical activity estimated for the longest-held occupation. All analyses will be adjusted for childhood social class, comorbidities, life-time smoking, and other confounders. We will have very good statistical power to detect odds ratios >=2.0, given likely risk factor prevalences. Interactions will be addressed through stratification of analyses by age group, race, histologic type, and EBV in tumor cells, as numbers permit; interactions between variables measuring childhood exposure and body size and physical activity will be considered in regression models. Study strengths include: 1) examination of under-studied risk factors novel for women; 2) a population basis; 3) strong data quality; 4) good to excellent statistical power; 5) re-reviewed diagnoses; 6) life-time body size and physical activity data; 7) detailed data on confounders. Study weaknesses include: 1) self-reported data; 2) limitation to strenuous leisure-time physical activity; 3) poor statistical power to examine associations in some subgroups; 4) potential recall bias and modest selection bias in controls.
描述(由申请人提供):
何杰金氏病(HD)是一种常见的癌症,其病因远未确定,很少有新的线索已被确定。零散的报告将HD风险与较高的身高,较重的体重和较少的体力活动联系起来。体型和体力活动被认为会影响免疫功能和激素调节,两者都被认为与HD病因相关,但它们对HD风险的影响很少被考虑,特别是在女性中。我们建议检查女性HD的风险与终生的身体大小和体力活动相关,以检验以下假设:1)成年身高和儿童期相对身高与HD风险增加相关。2)出生体重和整个成年期身高(体重指数)调整后的体重与HD风险相关。3)在青春期和成年期进行剧烈体力活动的频率与HD风险相关。我们将在一项已完成的基于人群的HD女性病例对照研究中收集详细的面对面访谈数据,这些数据具有高应答率,组织学重新审查诊断,以及312例病例和325例随机数字拨号控制的几乎完整的数据,这些数据与年龄和种族病例频率匹配。通过逻辑回归,我们将计算比值比来估计与以下因素相关的风险:成年身高; 8岁和12岁时的相对身高;出生体重;成年后身高调整后的体重;以及青少年和成年期的休闲时间剧烈体力活动的频率和最长职业的体力活动估计。所有分析都将根据儿童社会阶层、合并症、终生吸烟和其他混杂因素进行调整。我们将有很好的统计能力来检测比值比>=2.0,考虑到可能的风险因素患病率。如果数量允许,将通过按年龄组、种族、组织学类型和肿瘤细胞中的EBV对分析进行分层来解决相互作用;将在回归模型中考虑测量儿童期暴露与体型和体力活动的变量之间的相互作用。研究优势包括:1)检查未充分研究的女性新风险因素; 2)人群基础; 3)强大的数据质量; 4)良好至优秀的统计功效; 5)重新审查诊断; 6)终生体型和体力活动数据; 7)混杂因素的详细数据。研究弱点包括:1)自我报告的数据; 2)限制剧烈的休闲时间体力活动; 3)在某些亚组中检查关联的统计能力较差; 4)控制组中潜在的回忆偏倚和适度的选择偏倚。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SALLY L GLASER其他文献
SALLY L GLASER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SALLY L GLASER', 18)}}的其他基金
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM
监测、流行病学和最终结果计划
- 批准号:
7962359 - 财政年份:2003
- 资助金额:
$ 6.97万 - 项目类别:
Rapid Response Surveillance Study #09-5 - Constructing Geographic Areas in GIS fo
快速反应监测研究
- 批准号:
7962385 - 财政年份:2003
- 资助金额:
$ 6.97万 - 项目类别:
Patterns of Care - Dx 2006 Feasibility Adolescent and Young Adult
护理模式 - Dx 2006 青少年和年轻人的可行性
- 批准号:
7962455 - 财政年份:2003
- 资助金额:
$ 6.97万 - 项目类别:
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM
监测、流行病学和最终结果计划
- 批准号:
7542322 - 财政年份:2003
- 资助金额:
$ 6.97万 - 项目类别:
VALIDITY OF SELF REPORTED FAMILY HISTORY OF LYMPHOMAS
自我报告的淋巴瘤家族史的有效性
- 批准号:
6197354 - 财政年份:2000
- 资助金额:
$ 6.97万 - 项目类别:
VALIDITY OF SELF REPORTED FAMILY HISTORY OF LYMPHOMAS
自我报告的淋巴瘤家族史的有效性
- 批准号:
6378136 - 财政年份:2000
- 资助金额:
$ 6.97万 - 项目类别:
RELIABILITY OF EBV DETECTION IN HODGKINS DISEASE TUMORS
霍奇金病肿瘤中 EBV 检测的可靠性
- 批准号:
2655906 - 财政年份:1998
- 资助金额:
$ 6.97万 - 项目类别:
RELIABILITY OF EBV DETECTION IN HODGKINS DISEASE TUMORS
霍奇金病肿瘤中 EBV 检测的可靠性
- 批准号:
2896368 - 财政年份:1998
- 资助金额:
$ 6.97万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 6.97万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 6.97万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 6.97万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 6.97万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 6.97万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 6.97万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 6.97万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 6.97万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 6.97万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 6.97万 - 项目类别: